ATE355288T1 - Verbindungen und therapeutische methoden - Google Patents
Verbindungen und therapeutische methodenInfo
- Publication number
- ATE355288T1 ATE355288T1 AT00926538T AT00926538T ATE355288T1 AT E355288 T1 ATE355288 T1 AT E355288T1 AT 00926538 T AT00926538 T AT 00926538T AT 00926538 T AT00926538 T AT 00926538T AT E355288 T1 ATE355288 T1 AT E355288T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- therapeutic methods
- treatment
- diseases
- methods
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- ZXCZNUMWHATQSR-UHFFFAOYSA-N 10,20-diazapentacyclo[11.8.0.03,11.04,9.014,19]henicosa-1(13),3,5,7,9,11,14,16,18,20-decaene Chemical class C1=NC2=CC=CC=C2C2=C1CC1=C(C=CC=C3)C3=NC1=C2 ZXCZNUMWHATQSR-UHFFFAOYSA-N 0.000 abstract 1
- 241000224482 Apicomplexa Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ0373A AUPQ037399A0 (en) | 1999-05-14 | 1999-05-14 | Novel compounds and therapeutic methods |
| AUPQ0506A AUPQ050699A0 (en) | 1999-05-21 | 1999-05-21 | Novel compounds and therapeutic methods-ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE355288T1 true ATE355288T1 (de) | 2006-03-15 |
Family
ID=25646057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00926538T ATE355288T1 (de) | 1999-05-14 | 2000-05-12 | Verbindungen und therapeutische methoden |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6632822B1 (de) |
| EP (1) | EP1178988B1 (de) |
| JP (1) | JP2002544275A (de) |
| AT (1) | ATE355288T1 (de) |
| CA (1) | CA2372032A1 (de) |
| DE (1) | DE60033649D1 (de) |
| WO (1) | WO2000069856A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
| WO2006036969A2 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Formation of barrier layer |
| US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US8312836B2 (en) | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
| US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US8367099B2 (en) | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
| US8001922B2 (en) | 2004-09-28 | 2011-08-23 | Atrium Medical Corporation | Application of a coating on a medical device |
| US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
| US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
| CA2626030A1 (en) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
| JP2010508897A (ja) | 2006-11-06 | 2010-03-25 | アトリウム メディカル コーポレーション | コーティングされた外科用メッシュ |
| US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
| EP3613729A1 (de) | 2009-06-10 | 2020-02-26 | Chugai Seiyaku Kabushiki Kaisha | Tetrazyklische verbindungen |
| US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
| EP2593141B1 (de) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Zusammensetzung und verfahren zur veränderung der geschwindigkeit einer hydrolyse ausgehärteter materialien auf ölbasis |
| CN103052386B (zh) | 2010-08-20 | 2016-03-02 | 中外制药株式会社 | 含有四环化合物的组合物 |
| US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
| SG11201502211QA (en) | 2012-09-25 | 2015-05-28 | Chugai Pharmaceutical Co Ltd | Ret inhibitor |
| EP4397659A3 (de) | 2014-04-25 | 2024-10-02 | Chugai Seiyaku Kabushiki Kaisha | Zubereitung mit hochdosierter tetracyclischer verbindung |
| CN106458967A (zh) | 2014-04-25 | 2017-02-22 | 中外制药株式会社 | 四环化合物的新结晶 |
| TWI718102B (zh) | 2014-08-08 | 2021-02-11 | 日商中外製藥股份有限公司 | ４環性化合物的非晶質體 |
| US11077093B2 (en) | 2015-01-16 | 2021-08-03 | Chugai Seiyaku Kabushiki Kaisha | Combination drug |
| EP3848361B1 (de) | 2018-09-04 | 2025-01-22 | Chugai Seiyaku Kabushiki Kaisha | Verfahren zur herstellung einer tetracyclischen verbindung |
| CN119326763B (zh) * | 2024-10-28 | 2025-10-28 | 中南大学 | 7H-吲哚[2,3-j]菲啶-7,13(8H)-二酮用作JAK2抑制剂以及用于制备缓解、治疗胰腺癌的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001515839A (ja) | 1997-07-18 | 2001-09-25 | ジョージタウン・ユニバーシティ | 二環式向代謝性グルタミン酸受容体リガンド |
| JP2003512422A (ja) | 1999-10-29 | 2003-04-02 | メルク シャープ エンド ドーム リミテッド | ベンズイミダゾールｎｍｄａ／ｎｒ２ｂアンタゴニストを使用する疼痛の治療方法 |
-
2000
- 2000-05-12 US US09/980,506 patent/US6632822B1/en not_active Expired - Fee Related
- 2000-05-12 EP EP00926538A patent/EP1178988B1/de not_active Expired - Lifetime
- 2000-05-12 JP JP2000618273A patent/JP2002544275A/ja not_active Withdrawn
- 2000-05-12 WO PCT/AU2000/000458 patent/WO2000069856A1/en not_active Ceased
- 2000-05-12 DE DE60033649T patent/DE60033649D1/de not_active Expired - Lifetime
- 2000-05-12 CA CA002372032A patent/CA2372032A1/en not_active Abandoned
- 2000-05-12 AT AT00926538T patent/ATE355288T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6632822B1 (en) | 2003-10-14 |
| CA2372032A1 (en) | 2000-11-23 |
| JP2002544275A (ja) | 2002-12-24 |
| EP1178988A1 (de) | 2002-02-13 |
| EP1178988B1 (de) | 2007-02-28 |
| EP1178988A4 (de) | 2004-10-06 |
| WO2000069856A1 (en) | 2000-11-23 |
| DE60033649D1 (de) | 2007-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355288T1 (de) | Verbindungen und therapeutische methoden | |
| WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
| DE60029799D1 (de) | Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe | |
| ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
| DE60038183D1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
| TR199903331T2 (xx) | Farnesil protein transferas engelleyicileri. | |
| MXPA02006029A (es) | Lipopeptidos novedosos como agentes antibacterianos. | |
| DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| MXPA02006030A (es) | Lipopeptidos como agentes antibacterianos. | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE329897T1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen | |
| EP0939627A4 (de) | Pentafluorobenzensulfonamide und analoge | |
| IL176007A0 (en) | Antibodies specific to c35 and pharmaceutical compositions containing the same | |
| AU3304400A (en) | Tetrahydropyran derivatives and their use as therapeutic agents | |
| WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
| IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
| YU13301A (sh) | Muskarinski agonisti i antagonisti | |
| ES2144054T3 (es) | Complejos de tri(platino). | |
| SE0003476D0 (sv) | Compounds | |
| TR200103638T2 (tr) | IL-8 Reseptör antagonistleri | |
| ATE432936T1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
| DE69612056D1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
| MXPA06007007A (es) | Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores. | |
| DE69514100D1 (de) | Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel | |
| DE60206599D1 (de) | Biotin-derivate und ihre konjugaten mit chelatierungsmitteln |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |